BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 9748119)

  • 1. Prevention of intestinal toxic effects and intensification of irinotecan's therapeutic efficacy against murine colon cancer liver metastases by oral administration of the lipopeptide JBT 3002.
    Shinohara H; Killion JJ; Kuniyasu H; Kumar R; Fidler IJ
    Clin Cancer Res; 1998 Sep; 4(9):2053-63. PubMed ID: 9748119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon alpha in a murine hepatic metastasis model.
    Arroyo PJ; Bash JA; Wallack MK
    Cancer Immunol Immunother; 1990; 31(5):305-11. PubMed ID: 2376048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells.
    Ohnishi Y; Fujii H; Hayakawa Y; Sakukawa R; Yamaura T; Sakamoto T; Tsukada K; Fujimaki M; Nunome S; Komatsu Y; Saiki I
    Jpn J Cancer Res; 1998 Feb; 89(2):206-13. PubMed ID: 9548449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-induced microbial dysbiosis disrupts irinotecan (CPT-11) metabolism and increases gastrointestinal toxicity in a murine model.
    Meng J; Abu YF; Zhang Y; Zhou Y; Xie Y; Yan Y; Tao J; Ramakrishnan S; Chen C; Roy S
    Br J Pharmacol; 2023 May; 180(10):1362-1378. PubMed ID: 36562107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between development of diarrhea and the concentration of SN-38, an active metabolite of CPT-11, in the intestine and the blood plasma of athymic mice following intraperitoneal administration of CPT-11.
    Araki E; Ishikawa M; Iigo M; Koide T; Itabashi M; Hoshi A
    Jpn J Cancer Res; 1993 Jun; 84(6):697-702. PubMed ID: 8340259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KML001 displays vascular disrupting properties and irinotecan combined antitumor activities in a murine tumor model.
    Moon CH; Lee SJ; Lee HY; Lee JC; Cha H; Cho WJ; Park JW; Park HJ; Seo J; Lee YH; Song HT; Min YJ
    PLoS One; 2013; 8(1):e53900. PubMed ID: 23326531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model.
    Sato M; Mizuta K; Han Q; Morinaga S; Kang BM; Kubota Y; Mori R; Baranov A; Kobayashi K; Ardjmand D; Kobayashi N; Bouvet M; Ichikawa Y; Nakajima A; Hoffman RM
    In Vivo; 2024; 38(3):1058-1063. PubMed ID: 38688611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.
    Bhatt AP; Pellock SJ; Biernat KA; Walton WG; Wallace BD; Creekmore BC; Letertre MM; Swann JR; Wilson ID; Roques JR; Darr DB; Bailey ST; Montgomery SA; Roach JM; Azcarate-Peril MA; Sartor RB; Gharaibeh RZ; Bultman SJ; Redinbo MR
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7374-7381. PubMed ID: 32170007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients.
    Ramírez J; Wu K; Janisch L; Karrison T; House LK; Innocenti F; Cohen EE; Ratain MJ
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1629-32. PubMed ID: 21861128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan and Δ⁸-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers.
    Lucić Vrdoljak A; Fuchs N; Mikolić A; Žunec S; Brčić Karačonji I; Jurič A; Prester L; Micek V; Neuberg M; Čanović S; Mršić G; Kopjar N
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29865166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362.
    Utsugi T; Dinney CP; Killion JJ; Fidler IJ
    Cancer Immunol Immunother; 1991; 33(6):375-81. PubMed ID: 1878891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative Nanoparticulate Strategies in Colon Cancer Treatment: A Paradigm Shift.
    Yadav R; Bhawale R; Srivastava V; Pardhi E; Bhalerao HA; Sonti R; Mehra NK
    AAPS PharmSciTech; 2024 Mar; 25(3):52. PubMed ID: 38429601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized rat models better mimic patients with irinotecan-induced severe diarrhea.
    Zheng Z; Du T; Gao S; Yin T; Li L; Zhu L; Singh R; Sun R; Hu M
    Toxicol Mech Methods; 2024 Jun; 34(5):572-583. PubMed ID: 38390772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction to "Anti-PD-1 therapy for advanced colorectal cancer based on intestinal microecology" H. Pi, S. Liang, H. Liu, S. Lu, L. Huang, J. Biochem. Mol. Toxicol. 2023, e23438. https://doi.org/10.1002/jbt.23438.
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23701. PubMed ID: 38558224
    [No Abstract]   [Full Text] [Related]  

  • 15. Cobimetinib and Irinotecan Liposome.
    Pickren EB; Waddell JA; Solimando DA
    Hosp Pharm; 2016 Mar; 51(3):208-211. PubMed ID: 38745581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y-320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy.
    Hong J; Jing S; Zhang Y; Chen R; Owusu-Ansah KG; Chen B; Xie H; Zhou L; Zheng S; Jiang D
    Am J Transl Res; 2020; 12(2):551-562. PubMed ID: 32194903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis.
    Swami U; Goel S; Mani S
    Curr Drug Targets; 2013 Jun; 14(7):777-97. PubMed ID: 23597015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin but not irinotecan impairs posthepatectomy liver regeneration in a murine model.
    Soriano PA; Liu N; Castillo E; Foster B; Artinyan A; Kim J; Huang W; Wagman LD
    Int J Hepatol; 2011; 2011():490463. PubMed ID: 22164336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine.
    Barthel BL; Zhang Z; Rudnicki DL; Coldren CD; Polinkovsky M; Sun H; Koch GG; Chan DC; Koch TH
    J Med Chem; 2009 Dec; 52(23):7678-88. PubMed ID: 19634903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies.
    Gibson RJ; Keefe DM
    Support Care Cancer; 2006 Sep; 14(9):890-900. PubMed ID: 16604351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.